• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>PowerShares Active Mega Cap

PowerShares Active Mega Cap

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Merck Announces Submission of Supplemental Biologics License Application (sBLA) to U.S. FDA for KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer

    Merck Announces Submission of Supplemental Biologics License Application (sBLA) to U.S. FDA for KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer

  2. Research and Markets: How to Format Succinct and Comprehensive 510(k)s and PMAs Course: North Carolina, USA, 9th, 10th of July 2015

    Research and Markets: How to Format Succinct and Comprehensive 510(k)s and PMAs Course: North Carolina, USA, 9th, 10th of July 2015

  3. HeartWare Achieves Primary Endpoint In The ENDURANCE Destination Therapy Clinical Trial

    HeartWare Achieves Primary Endpoint In The ENDURANCE Destination Therapy Clinical Trial

  4. Georgia Pecans Partner with Schwinn Bicycles for Healthy Alliance

    Georgia Pecans Partner with Schwinn Bicycles for Healthy Alliance

  5. Fund Times: Former Growth Manager Scores GOP Victory

    Plus, changes at AIM, Fidelity, and Matthews, and more.

  6. Changes Are Afoot in U.S. Medical Device Regulations

    Orthopedics remain at risk, but shares are priced below worst-case scenarios.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.